210 



In an Apnl 2u, ["^hl memorandum, senior scientist H. Wakeman ot' Phihp Mom-, 

 laid out his thoughts on a policy the company might follow as a result ot the 

 reopening of the smoking and health question... " 



if the "Tar Derby " stans up again in the United Sutes. I think we 

 should try to be the first to market a cigarene delivering considerably 

 less, of one or more of those substances that have been reponed to be 

 irritating to human skin or mucous membrane. 



Let's speed up our activities on the solvent extraction of tobacco for the 

 purpose of reducing the quantity of TPM, nicotine and gas phase 

 materials delivered from the cigarette blend. 



Finally, lets hasten our search for an additive (catalyst) that might be 

 incorporated into the cigarette blend for the purpose of reducing the 

 irritating substances in smoke. 



On October 24. 1963 in a personal and confidential memorandum, H. Wakeham 



of Philip Morris provided a "Technical Forecast" to Mr. Hugh Cullman. It read. 



You have requested a "technical forecast outlining those areas where 

 the cigarette industry might be most subject to criticism and suggesting 

 those elements in smoke which might be most accused by either the 

 medical profession or exploited by our competiton. " We now have 

 accumulated a good deal of documentation on this subject. Rather 

 than to subject you to all this I will present here our considered 

 judgement in the matter. If you should wish to go into further detail, it 

 might be more practical to give you an oral review. 



We believe that the health critics are following three main lines of 

 attack: 



(1) Chemical carcinogenesis of the lungs by smoke constituents; 



(2) Irritation from smoke components leading to chronic bronchitis and 

 emphysema; and 



(3) Cardiovascular effects due mainly to nicotine in the smoke. 



... The Cardiovascular Effects in smoke are believed to be mainly due to 

 nicotine and have been thoroughly explored in literature and 

 conference. We do not believe this will be a specific area of attack. If 

 forced to, we could produce a fairly tasty low aicotine product. 



On November 21, 1963, Mr. R.H. Blackmore sent a confidential memo to Dr. A. 



Bavley concenung "Project 0100. " The memo summarizes a planning meeting to 



"establish the major objectives for Project 0100 during 1964. The following 



exceipt is worth noting. 



Dr. Bavley prefaced the meeting with the statement that the major 

 objective of the Research Division for 1964 is to develop a "Medically 



